Image

Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

Heart attacks caused by the complete blockage of a heart artery are treated by opening it with a stent. However, most people will also have 'non-culprit' narrowings found in their other arteries at this time.

Although in general people do better if these non-culprit narrowings are also treated with stents if they look severe, this process has problems. This is because narrowings that look severe may be stable and not cause any trouble. For these people a stent is a wasted procedure and unnecessary risk. On the other hand, narrowings that are currently left alone because they appear mild, may progress and cause a heart attack.

Participants who have had a heart attack will have a scan from inside the heart arteries during an angiogram (optical coherence tomography, OCT) and a magnetic resonance angiogram (MRA).

If the investigators can show that it is possible to accurately predict which non-culprit narrowings are going to progress and which are going to stabilise, medical professionals may be able to better target their treatments after a heart attack.

Eligibility

Inclusion Criteria:

  • Successful primary percutaneous coronary intervention (PCI) within the previous week with no major complications at the index procedure
  • Bystander disease in a non-culprit vessel planned for clinically indicated staged angiography +/- PCI
  • Able to provide written informed consent.

Exclusion Criteria:

  • Cardiogenic shock requiring intubation, inotropes or a mechanical support device
  • Creatinine clearance <30ml/min
  • Prior coronary artery bypass grafting
  • Life expectancy less than 3 years
  • Pregnancy.
  • Target lesion in the left main coronary artery
  • Severe calcification or tortuosity that would threaten safe placement of a pressure wire or OCT catheter
  • Chronic total occlusion of a major epicardial vessel.

Study details

Coronary Artery Disease, ST Elevation Myocardial Infarction, Ischemic Heart Disease

NCT05781087

Guy's and St Thomas' NHS Foundation Trust

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.